EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Soluble VCAM1 and GSK3β Improves Cerebrovascular Function and Reduces Stroke Pathology in Diabetic Mice

Masuma Akter Brishti, Mousumi Mandal iD, Udai Pratap Singh iD, Tauheed Ishrat, M Dennis Leo iD

Cells · 04.03.2026 · 15 (5) · 455

DOI: 10.3390/cells15050455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 04.03.2026. Verfasst von Masuma Akter Brishti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Vascular Cell Adhesion Molecule-1, Diabetes Mellitus, Experimental, Stroke. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Pharmacy, University of Tennessee Health Science Center, Drug Discovery Center Pilot.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) features insulin resistance that promotes cerebrovascular injury, yet the immune signals linking metabolic stress to vascular dysfunction remain unclear. We tested the hypothesis that insulin resistance and soluble vascular cell adhesion molecule-1 (sVCAM1) act through complementary pathways in mast cells (MCs) to raise circulating histamine levels and impair cerebral vascular function. In a high-fat diet (HFD) plus low-dose streptozotocin (STZ) model, plasma histamine rose sharply after the onset of insulin resistance and remained elevated. Plasma sVCAM1 levels also increased after insulin resistance. In vitro, recombinant sVCAM1 upregulated histidine decarboxylase (HDC) in native MCs in a dose-dependent manner, indicating a shift toward histamine synthesis, but did not enhance degranulation. In contrast, pharmacological inhibition of Akt with MK2206 activated Glycogen Synthase Kinase 3 beta (GSK3β) and increased MC degranulation without affecting HDC expression. Diabetic endothelial cell monolayers exhibited a ~twofold reduction in transendothelial electrical resistance consistent with impaired blood–brain barrier (BBB) integrity. Diabetic cerebral arteries showed receptor remodeling that favored constriction with histamine H1 receptor (H1R) expression increasing in vascular smooth muscle, while endothelial H1R and histamine H2 receptor (H2R) decreased. Functionally, insulin treatment lowered HOMA2-IR in T2D mice but did not restore cerebral artery myogenic tone or improve stroke outcomes after distal middle cerebral artery occlusion (dMCAO). Neutralizing VCAM1 with a monoclonal antibody reduced circulating sVCAM1 and histamine levels, and, together with the GSK3β inhibitor Tideglusib, stabilized MCs, normalized cerebral artery tone, and reduced post-MCAO infarct size and edema. These findings identify two distinct yet complementary mast cell pathways in T2D, highlight an immune-vascular interface that drives cerebrovascular dysfunction, and propose sVCAM1 blockade plus GSK3β inhibition as rational strategies to protect cerebral vascular function in the diabetic brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Synthase Kinase 3 betaVascular Cell Adhesion Molecule-1Diabetes Mellitus, ExperimentalStrokeAnimalsMaleMiceMast CellsHistamineBlood-Brain BarrierInsulin ResistanceMice, Inbred C57BLDiabetes Mellitus, Type 2Histidine DecarboxylaseDiet, High-Fat

Stichwörter der Autor:innen

Glycogen Synthase Kinase 3 betaHFD-STZ modelinsulin resistancemast cellssoluble vascular cell adhesion molecule-1type 2 diabetes

Substanzen

Glycogen Synthase Kinase 3 betaVascular Cell Adhesion Molecule-1HistamineHistidine Decarboxylase

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Mousumi Mandal, Udai Pratap Singh, M Dennis Leo

Förderung

  • College of Pharmacy, University of Tennessee Health Science Center
  • Drug Discovery Center Pilot

Zitieren

APA

Brishti, M. A., Mandal, M., Singh, U. P., Ishrat, T., & Leo, M. D. (2026). Targeting Soluble VCAM1 and GSK3β Improves Cerebrovascular Function and Reduces Stroke Pathology in Diabetic Mice. Cells, 15(5), 455. https://doi.org/10.3390/cells15050455

Vancouver

Brishti MA, Mandal M, Singh UP, Ishrat T, Leo MD. Targeting Soluble VCAM1 and GSK3β Improves Cerebrovascular Function and Reduces Stroke Pathology in Diabetic Mice. Cells. 2026;15(5):455. doi:10.3390/cells15050455

BibTeX
@article{Brishti2026,
  author = {Brishti, Masuma Akter and Mandal, Mousumi and Singh, Udai Pratap and Ishrat, Tauheed and Leo, M Dennis},
  title = {Targeting Soluble VCAM1 and GSK3β Improves Cerebrovascular Function and Reduces Stroke Pathology in Diabetic Mice},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {455},
  doi = {10.3390/cells15050455}
}
Kostenlos starten →